News | April 28, 2026
Essilor Stellest lens positioned as key breakthrough in myopia control in India
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
Revvity is positioning its technologies as a connected engine for discovery
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
